Molecular docking confirmed fenretinide as a potential therapeutic agent.<h4>Conclusion</h4>This study provides convergent evidence from genetic, multi-omics, and experimental analyses that oxidative stress-related genes, particularly <i>ACADVL</i>, may increase susceptibility to tinnitus through metabolic and inflammatory dysregulation. This evidence concerns the gene ACADVL and Tinnitus.